The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I).La présente invention concerne des composés de formule (I), leur utilisation en tant quinhibiteurs de linteraction p53-MDM2, ainsi que des compositions pharmaceutiques comprenant lesdits composés de formule (I).